Medicare Part D Cost-Sharing Parameters To Be Set By CMS Under Proposal
The Centers for Medicare and Medicaid Services is proposing to set annual limits on drug cost sharing required by Medicare Part D and Medicare Advantage plans, according to a proposed rule released by the agency Oct. 9
You may also be interested in...
The Pharmaceutical Research and Manufacturers of America is highlighting the negative impact high cost-sharing can have on patient access to drugs, most recently in comments on the draft 2010 "call letter" for Part D plans
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials